Biosensors Market: By Product (Wearable, & Non-Wearable Biosensors), By Technology (Electrochemical, Piezoelectric, Optical, Thermal, & Other Biosensors), By Application, By End-User, & By Region-Forecast (2014-2021)

  • ID: 3919914
  • Report
  • 149 pages
  • IndustryARC
1 of 3
Biosensors provide qualitative and quantitative data for the real-time analysis and play a very important role to sense the biological environment. A biosensor is bioelectronics analytical tool that captures the biological signal from analyte by using a physicochemical detector and translate these signals into measurable outputs. Globally, development of nanotechnology/nanobiosensors, rise in the demand for home based POC devices, and increasing glucose monitoring in diabetic’s patients are the prime growth drivers of global biosensors market. In addition, increase in adoption of biosensors for non-medical applications, such as - the food industry, environmental monitoring, and biodefense and, emerging economies such as China, India and others, will create new opportunities for global biosensors market. However, higher cost of the research and development, and lack of standardization are the key restraints for global biosensors market.

This report identifies the global biosensors market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global biosensors market.

Biosensors Market

Geographically North America dominated global biosensors market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, and modernizing healthcare infrastructure in this region. Among all the end-users, point of care testing segment has the highest market share in global biosensors market.

This report segments global biosensors market on the basis of product, technology, application, end-user, and regional market as follows:
Biosensors Market, By Product: Wearable Biosensors, and, Non-Wearable Biosensors
Biosensors Market, By Technology: Electrochemical Biosensors, Piezoelectric Biosensors, Optical Biosensors, Thermal Biosensors, and Others
Biosensors Market, By Application: Medical, Food Toxicity Detection, Industrial Process Control, Agriculture, Environment, and Others
The report has focused study on biosensors market by basis of end-user such as: Point-of-Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry, and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the biosensors market.

Some of the major companies’ profiles in detail are as follows:
Abbott Point of Care, INC.
Acon Laboratories, INC.
Bayer AG
F. Hoffman La-Roche LTD.
Lifescan, INC.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Biosensors - Market Overview
2. Executive Summary
3. Biosensors Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Biosensors - Market Forces
4.1. Drivers
4.1.1. Development of nanotechnology/nanobiosensors
4.1.2. Rise in the demand for home based POC devices
4.1.3. Increasing glucose monitoring in diabetic’s patients
4.2. Restraints
4.2.1. The research and development having higher cost
4.2.2. Lack of standardization
4.3. Opportunities
4.3.1. Emerging economies
4.3.2. Increase in adoption of biosensors for non-medical applications, such as - the food industry, environmental monitoring, and biodefense
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Biosensors Market, By Product
5.1. Wearable Biosensors
5.2. Non-Wearable Biosensors
6. Biosensors Market, By Technology
6.1. Electrochemical Biosensors
6.2. Piezoelectric Biosensors
6.3. Optical Biosensors
6.4. Thermal Biosensors
6.5. Others
7. Biosensors Market, By Application
7.1. Medical
7.2. Food Toxicity Detection
7.3. Industrial Process Control
7.4. Agriculture
7.5. Environment
7.6. Others
8. Biosensors Market, By End-User
8.1. Point-of-Care
8.2. Home Diagnostics
8.3. Research Labs
8.4. Biodefense
8.5. Environmental Monitoring
8.6. Food Industry
8.7. Others
9. Global Biosensors Market, By Geography
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW
10. Biosensors - Market Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply - Contract
11. Company Profiles
11.1. Abbott Point of Care, INC.
11.1.1. Introduction
11.1.2. Financials
11.1.3. Key Insights
11.1.4. Key Strategy
11.1.5. Product Portfolio
11.1.6. SWOT Analysis
11.2. Acon Laboratories, INC.
11.2.1. Introduction
11.2.2. Financials
11.2.3. Key Insights
11.2.4. Key Strategy
11.2.5. Product Portfolio
11.2.6. SWOT Analysis
11.3. Bayer AG
11.3.1. Introduction
11.3.2. Financials
11.3.3. Key Insights
11.3.4. Key Strategy
11.3.5. Product Portfolio
11.3.6. SWOT Analysis
11.4. F. Hoffman La-Roche LTD.
11.4.1. Introduction
11.4.2. Financials
11.4.3. Key Insights
11.4.4. Key Strategy
11.4.5. Product Portfolio
11.4.6. SWOT Analysis
11.5. Lifescan, INC.
11.5.1. Introduction
11.5.2. Financials
11.5.3. Key Insights
11.5.4. Key Strategy
11.5.5. Product Portfolio
11.5.6. SWOT Analysis
11.6. Medtronic INC.
11.6.1. Introduction
11.6.2. Financials
11.6.3. Key Insights
11.6.4. Key Strategy
11.6.5. Product Portfolio
11.6.6. SWOT Analysis
11.7. Nova Biomedical Corporation
11.7.1. Introduction
11.7.2. Financials
11.7.3. Key Insights
11.7.4. Key Strategy
11.7.5. Product Portfolio
11.7.6. SWOT Analysis
11.8. Pharmaco-Kinesis Corporation
11.8.1. Introduction
11.8.2. Financials
11.8.3. Key Insights
11.8.4. Key Strategy
11.8.5. Product Portfolio
11.8.6. SWOT Analysis
11.9. Siemens AG
11.9.1. Introduction
11.9.2. Financials
11.9.3. Key Insights
11.9.4. Key Strategy
11.9.5. Product Portfolio
11.9.6. SWOT Analysis
11.10. Universal Biosensors
11.10.1. Introduction
11.10.2. Financials
11.10.3. Key Insights
11.10.4. Key Strategy
11.10.5. Product Portfolio
11.10.6. SWOT Analysis

"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown